Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

KV Pharmaceutical’s Q4 loss more than 7 times revenue
bizjournals.com
Saturday, February 11, 2012 - 12:37pm
tags:
KV Pharmaceutical
Watson Settles Patent Dispute
Yahoo/Zacks
Saturday, February 11, 2012 - 12:36pm
tags:
Watson Pharmaceuticals
Abbott Labs Offers Long, Solid Dividend History
Investors.com
Saturday, February 11, 2012 - 12:35pm
tags:
Abbott Laboratories
Incyte in Neutral Lane
Yahoo/Zacks
Saturday, February 11, 2012 - 12:33pm
tags:
Incyte
Big Pharma: 3 To Avoid, 1 To Buy
Seeking Alpha
Saturday, February 11, 2012 - 12:17pm
tags:
Abbott Laboratories, Eli Lilly, Merck, Bristol-Myers Squibb
1 Biotech to Buy Post-Plunge
Motley Fool
Saturday, February 11, 2012 - 11:56am
tags:
Astex
Why It's Time To Sell These 4 Healthcare Stocks
Seeking Alpha
Saturday, February 11, 2012 - 11:51am
tags:
Merck, Pfizer, Abbott Laboratories, Boston Scientific
The Truly Staggering Cost Of Inventing New Drugs
Forbes
Saturday, February 11, 2012 - 11:50am
tags:
R&D
Sanofi Beats Earnings Estimates
Yahoo/Zacks
Saturday, February 11, 2012 - 11:49am
tags:
Sanofi
The Skinny on Upcoming Obesity FDA Meetings
Motley Fool
Saturday, February 11, 2012 - 11:44am
tags:
Vivus, Qnexa, Arena Pharmaceuticals, lorcaserin, pixantrone, Cell Therapeutics, obesity, weight loss
Halozyme Therapeutics
Investors Business Daily
Saturday, February 11, 2012 - 11:42am
tags:
Halozyme
Celgene Takes Smart Risks, Invests For The Long Run
Investors.com
Saturday, February 11, 2012 - 11:41am
tags:
Celgene
Osiris Provides Update on Sanofi Deal
Yahoo/Zacks
Saturday, February 11, 2012 - 11:40am
tags:
Osiris Therapeutics, Sanofi, Prochymal, graft vs host disease
FDA proposed guidelines open the door to biosimilars
Reuters
Saturday, February 11, 2012 - 11:38am
tags:
FDA, biosimilars
Alnylam to Webcast Presentations at Upcoming Investor Conferences
Yahoo/BusinessWire
Saturday, February 11, 2012 - 11:37am
tags:
Alnylam
Biotech: A “Stock Picker’s Delight,” Says Morgan Stanley
Barron's
Saturday, February 11, 2012 - 11:36am
tags:
Biogen Idec, Cellgene, Gilead Sciences
Amyris shares tumble on outlook
Yahoo/AP
Saturday, February 11, 2012 - 11:35am
tags:
Amyris
LEO Pharma slapped with sales-rep overtime suit
Fierce Pharma
Friday, February 10, 2012 - 11:14am
tags:
overtime lawsuits, drug reps, LEO Pharma
[video] The Next Big Thing in Biotech: BIO CEO Conference
TheStreet.com
Friday, February 10, 2012 - 10:57am
tags:
BIO CEO Conference, biotech
WellPoint to Cease Branded Lipitor Coverage, Favor Generics
WSJ Online
Friday, February 10, 2012 - 10:56am
tags:
Lipitor, generics, statins, Pfizer, Wellpoint

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.